PTU - Polskie Towarzystwo Urologiczne
list of articles:

Comparision of results of nephron-sparing surgery (NSS) with surgical margins to 3 mm versus over 5 mm width in patients with renal cell carcinoma (RCC)
Article published in Urologia Polska 2005/58/2.

authors

Mieczysław Fryczkowski, Andrzej Kupilas, Andrzej Paradysz, Andrzej Potyka, Marcin Życzkowski
Katedra i Klinika Urologii w Zabrzu Śląskiej Akademii Medycznej w Katowicach
Kierownik kliniki: prof. dr hab. Mieczysław Fryczkowski

keywords

kidney, kidney cancer, NSS, surgical margins, margin width

summary

introduction and objectives
The aim of the present study is to compare the results of nephron-sparing surgeries (NSS) with various surgical margins in patients with renal cell carcinoma (RCC).
material and methods
146 NSS operations were performed in 142 patients aged between 25-75 years (mean 58.2 years) from 01.1988 to 08.2004. Patients were divided into two groups. Group I and II consisted of 97 patients with surgical margin of less then 3 mm in length and 45 patients with surgical margin of more then 5 mm (mean 7.5 mm) in length respectively. Surgical margin and probes taken from surrounding kidney were histopathologically assessed. 11 clinical and morphological factors were statistically analyzed. Follow-up examinations were performed in accordance to EORTC indications from 06 to 204 months after NSS (mean 61.4 mths).
results
There was significantly more typical RCC, G1 and T1a tumors in Group I then in Group II. In comparison to Group I, there was more T1b, G2 tumors in Group II and the follow-up was shorter in Group II. Way of qualification to NSS influenced 5-year survival, progression and positive surgical margins rates.
conclusions
1. Progression rates, survival time and recurrence rate do not depend on surgical margins length.
2. Disease progression, survival time and length of surgical margins are influenced by indications for NSS.
3. Positive surgical margines rate is negative prognostic factor and depends on qualification to NSS.

references

  1. Szerokość marginesu chirurgicznego u chorych z rakiem nerki poddanych NSS nie wpływa istotnie statystycznie na odsetek miejscowych wznów i progresję choroby ani czas przeżycia pięcioletniego.
  2. W grupie chorych z marginesem do 3 mm jest więcej guzów T1a, RCC-typicum o niskim stopniu złośliwości histopatologicznej G1 przy wyższym czasie obserwacji.
  3. Rodzaj wskazań do NSS rzutuje istotnie na wyniki progresji choroby, czas przeżycia pięcioletniego, i jest czynnikiem wymuszającym szerokość marginesu chirurgicznego.
  4. Odsetek dodatnich marginesów chirurgicznych uzależniony jest od kwalifikacji do NSS i wpływa istotnie na czas przeżycia i gorsze wyniki po operacji.
  5. Piśmiennictwo / References
  6. Berdjis N, Novotny V, Oehlschager S et al: Impact of resection margin width after nephron-sparing surgery for renal cell cancer. Eur Urol 2004; supl. 2, 282.
  7. Piper NY, Bishoff JT, Magee CH et al: Is 1 cm margins necessary during nephron-sparing surgery for renal cell carcinoma. Urology 2001; 58; 849-852.
  8. Castillo EA, Lioou LS, Abrahams WA et al: Prognostic importance of resection margins with after nephron-sparing surgery for renall cell carcinoma. Urology 2002; 60; 993-997.
  9. Morgan WR, Zincke H: Progression and survival after renal conserving surgery for renal cell carcinoma. Experience with 104 patients and extendet follow-up. J Urol 1990; 144; 852-857.
  10. Schlichter A, Wunderlich K, Junker K et al: Where are the limits of elective nephron-sparing surgery in real cell carcinoma. Eur Urol 2000; 37; 517-520.
  11. Mejean A, Galon C, Joly O et al: Renal cell carcinoma. Identyfication of a risk factor for VHL patients to develop to RCC. Eur Urol 2000; 37, supl. 2, abstr. 517.
  12. Novick AC, Zincke H, Neves RJ, Topley HM: Surgical enucleation for renal cell carcinoma. J Urol 1986; 136; 235-238.
  13. Marshall FF, Taxy JN, Fishman EK, Chang R: The fasibility of surgical enucleation for renal cell carcinoma. J Urol 1986; 135; 231-235.
  14. Lerner SE, Hawkins CA, Blute ML et al: Disease outcome in patients with low stage renal cell carcinoma treated with nephron-sparing or radical surgery. J Urol 1996; 156; 1868-1872.
  15. Stephens R, Graham SD: Enucleation of tumor versus partial nephrectomy as conservative treatment of renal cell carcinoma. Cancer 1990; 65; 2663-2667.
  16. Blackley SK, Ladaga L, Wodfitt RA, Schellhamer PF et al: Ex situ study of the effcctivenes of enucleation in patients with renal cell carcinoma. J Urol 1988; 140; 6-10.
  17. Szcześniak C, Chłosta P, Dzik T, Borówka A: Ocena doszczętności onkologicznej wyłuszczenia guza nerki na podstawie badań doświadczalnych. Urol Pol 2003; 53; 34-41.
  18. Rosenthal CA, Kraft R, Zingg EJ: Organ presserving surgery in renal cell carcinoma. Tumor enucleation versus partial kidney resection. Eur Urol 1984; 10; 222-228.
  19. Fergany AF, Haffez KS, Novick AC: Long-term reults of nephron-sparing surgery for localized renal cell carcinoma. 10-year follow-up. J Urol 2000; 163, 442-445.
  20. Rocco-Rosseti S, Muto G: Considerazioni anatomische sull?enucleatilita degli adenocarcinomas renali. 5-th Congres of the European Intr. renal surgical Sociaty. Trieste 1980; 1; 3-8.
  21. Wunderlich H, Reichel I, Schlichter A et al: Nephron-sparing surgery for renal cell carcinoma 4 cm or less in diameter. Indicated or under treated. J Urol 1998; 159; 1485-1489.
  22. Quon-Lin L, Hong-Wei G, Qu-Pong Z: Optimal margins in nephron-sparing surgery for renal cell carcinoma. Eur Urol 2001; 35, supl. 1; 94-95.
  23. Sutherland SE, Resnick M, Mac Lenan GT, Goldman HB: Does the size of the surgical margin in partial nephrectomy for renal cell cancer really maatter. J Urol 2002; 167; 61-64.
  24. Skrekas T, Farmakis A, Lycourinas M et al: The effect of surgical margins size on local tumor recurrence after partial nephrectomy for localized renal cell carcinoma. Eur Urol 2003; 35, supl. 2; abstr. 213.
  25. Puppo O, Intrani C, Majotta A et al: Nephron-sparing surgery leaving 2-3 mm margin. Review of 94 caees. Eur Urol 2003, 35, supl. 1, abstr. 214.

correspondence

Mieczysław Fryczkowski
Klinika Urologii w Zabrzu ŚAM w Katowicach
ul. 3 Maja 13/15
41-800 Zabrze
tel./fax (032) 271 65 11
andrzej.kupilas@wp.pl